Drug-resistant TB

Лекарственно-устойчивый туберкулез: интерпретация результатов быстрых молекулярных тестов

Author(s): WHO

Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, Russian, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization

Author(s): WHO

Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization

Author(s): The Union

Year: 2022

Filed under: clinical, Course, DR-TB, drug resistance, Drug-resistant TB, e-course, e-learning, learning, lung health, program, TB, TB Union, The Union, Tuberculosis, Ukraine, Ukrainian

Author(s): The Union

Year: 2021

Filed under: clinical, Course, DR-TB, drug resistance, Drug-resistant TB, e-course, e-learning, learning, lung health, program, TB, TB Union, The Union, Tuberculosis

Author(s): WHO

Filed under: DR-TB, drug safety, drug safety monitoring, Drug-resistant TB, Guidelines, Management, management framework, performance indicators, TB, Treatment, treatment regimens, Tuberculosis, WHO, World Health Organization

Author(s): U.S. Government

Year: 2021

Filed under: drug resistance, Drug-resistant TB, MDR, mdr-tb, multidrug-resistant TB, Report

Author(s): World Health Organization

Year: 2021

Filed under: drug resistance, Drug-resistant TB, French, Guidance, Guidance and Tools, NTPs, Surveillance

Author(s): World Health Organization

Year: 2021

Filed under: drug resistance, Drug-resistant TB, Guidance, Guidance and Tools, NTPs, Surveillance

Author(s): National TB Programme Department of Public Health Ministry of Health and Sports The Republic of the Union of Myanmar

Year: 2017

Filed under: Burma, DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, Monitoring, NTP, program management, XDR-TB

Author(s): Challenge TB, KNCV Tuberculosis Foundation

Year: 2017

Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, multidrug-resistant TB, program management, Treatment, XDR-TB